Non-Small Cell Lung Cancer

Addressing Financial and Socioeconomic Barriers to Precision NSCLC Care: Jonathan Thompson, MD, MS

Weighing Relapse Risk Against Benefit in Advanced NSCLC Immunotherapy: Jonathan Thompson, MD, MS

Outcomes in NSCLC Rely on Equitable Access to Treatment: Frank Weinberg, MD, PhD

Navigating Perioperative Immunotherapy Decisions in Lung Cancer Care: Jonathan Thompson, MD, MS

Refining Treatment Timelines and Immunotherapy Strategies in Early-Stage NSCLC: Jonathan Thompson, MD, MS

Biomarker Testing, Perioperative Treatment in NSCLC: Frank Weinberg, MD, PhD

Expanding the Role of NGS and Retesting in Early and Refractory NSCLC: Jonathan Thompson, MD, MS

Embedding Reflex Biomarker Testing to Advance Precision Lung Cancer Care: Jonathan Thompson, MD, MS

Health System Fragmentation Undermines Timely Lung Cancer Testing: Julia Rotow, MD

Highlighting Disparities Among AAPI Women With Lung Cancer: Tabby Khan, MD, MPH